glp-1 results 26f, 5'1 GLP-1 actions in peripheral tissues.

[DOI] [PubMed] [Google Scholar] 23.Morrison R.F., Farmer S.R

2012;59(10):A4519

Recent advancements in GLP-1-based therapies 8.1

Its worth noting that these positive effects were only seen in patients taking long-acting GLP-1 receptor agonists (more commonly prescribed) and not in those using short-acting agents

Hyperinsulinemia and ectopic lipid accumulation promote activation of pro-inflammatory pathways, including Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-B) signaling and NLRP3 inflammasome activation, which in turn exacerbate loss of immune tolerance [52,53]

This helps our body manage blood sugar levels more effectively